Professor Andrew Tee



Prosiectau fel Prif Ymchwiliwr
null null 1 o 4 null null

Targeting glucose metabolism for the treatment of Birt Hogg Dube Syndrome - Cyllidwr:Partnership for Cures (01.10.2009 - 30.09.2010)
Restoring TSC pathology through autophagy induction and mTORC1 inhibition - Cyllidwr:Tuberous Sclerosis Association (01.03.2014 - 31.03.2019)
Identifying and characterising novel mammalian target of rapamycin (mTOR) substrates - Cyllidwr:Association for International Cancer Research (01.02.2007 - 28.02.2013)
Identifying therapies and drug targets for treatment of Birt-Hogg-Dube - Cyllidwr:Myrovlytis Trust (01.10.2011 - 30.09.2014)
The effects of amplified ROS production and elevated activity in BHD-null cells - Cyllidwr:Myrovlytis Trust (01.01.2011 - 31.12.2012)


Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 2 null null

Identification of the molecular defects in metabolic pathways associated with MECP2 deficiency - Cyllidwr:Newlife Foundation for Disabled Children (01.07.2013 - 30.06.2014)
Cancer Genetics Biomedical Research Unit - Cyllidwr:Welsh Government (HCRW) (31.03.2011 - 31.05.2015)
Characterising the role of exosomes in Tuberous Sclerosis complex - Cyllidwr:Tuberous Sclerosis Association (01.10.2018 - 30.09.2021)

Diweddarwyd y tro diwethaf ar 2020-23-11 am 22:06